Skip to navigation Skip to content

News release

Apotex donation helps Oak Valley Health respond to urgent capacity needs amid rapid community growth

Nov 17, 2025

MARKHAM, ON - As Markham and the surrounding region experience rapid population growth, Oak Valley Health's Markham Stouffville Hospital (MSH) is taking steps to expand capacity and improve access to care — thanks to a gift from Apotex Inc., the Canadian-based global health company.

Oak Valley Health serves York and Durham, two of Ontario's fastest-growing regions. Population growth — combined with an aging population — is placing increasing pressure on hospital services. Between 2022/23 and 2024/25, MSH saw a 12 per cent increase in Emergency Department (ED) visits, along with corresponding growth in admissions, clinic visits, laboratory services, and diagnostic services.

To help address these pressures, Apotex has donated a 16,000-square-foot modular building, now named the Apotex Administrative Building, along with a $100,000 contribution to fund the hospital's highest priority equipment needs. The modular facility, repurposed from Apotex's own operations, is now installed beside MSH's ED and used to relocate several key administrative teams.

The move frees up critical space within the hospital, creating room to expand both the ED and The Nanji Family Mental Health Services — two areas under significant strain from rising demand.

"Population growth in our region has outpaced our hospital's physical space," says Mark Fam, President & CEO, Oak Valley Health. "This gift allows us to move quickly to relieve capacity pressures, expand emergency and mental health services, and enhance the patient experience — without the delays of new construction. It's an innovative and sustainable solution that benefits everyone."

Apotex's contribution reflects its commitment to improving access to care and supporting community well-being. "As a force for health, we support care that's rooted in the community and aligned with real needs. This contribution helps Oak Valley Health expand access, grow with its population, and strengthen long-term resilience across the health system. It's one of the ways our Journey of Health strategy translates into meaningful, sustained impact," says Ray Shelley, President, Apotex Canada.

"We are incredibly grateful to Apotex for their forward-thinking approach of generosity," says Suzette Strong, CEO, Markham Stouffville Hospital Foundation. "Government funding alone can't meet all of our hospital's needs, which is why partnerships like this are so vital. Their commitment will have a lasting impact on our hospital's ability to remain a leader in providing exceptional care close to home, for generations to come."

Markham Stouffville Hospital Foundation exists to enable the growth of Oak Valley Health’s Markham Stouffville Hospital (MSH) by raising funds and awareness for its ongoing priorities and needs. Donations from the community fund life-saving medical equipment that helps to ensure the delivery of first-class health care at MSH. Learn more at mshf.on.ca.

Oak Valley Health is one of Ontario's leading community health care organizations, dedicated to delivering high quality, patient-centred care. Across our two hospitals—Markham Stouffville Hospital and Uxbridge Hospital—as well as the Reactivation Care Centre, more than 480,000 patients are cared for annually. We offer diagnostic and emergency services and deliver clinical programs in acute care medicine and surgery, addictions and mental health, and childbirth and children's services. We are proud to be part of the Eastern York Region North Durham Ontario Health Team (EYRND OHT), providing expanded access to care through the Community Health Clinics (CHC) and the Virtual Urgent Care Clinic (VUCC). With a team of 657 professional staff—including physicians, midwives, and dentists—alongside over 3,400 staff, and over 1,000 volunteers, we are honoured to care. Our commitment to celebrating our people, fostering connections, and driving innovative growth, is providing integrated care for healthier communities, and delivering an extraordinary patient experience to patients, families and residents of Markham, Whitchurch-Stouffville, Uxbridge, and beyond. Learn more at oakvalleyhealth.ca.

Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. Learn more at apotex.ca.

Media Contacts

Michelle Lee Hoy, Oak Valley Health
416-270-6009
[email protected]

Madeline Cuadra, MSH Foundation
416-877-8425
[email protected]

Apotex
[email protected]

Media inquries

Have a question for our media team? Fill out our inquiries form, and we’ll get back to you as soon as possible.

Contact our media team

Latest news

  • Sep 18, 2026

    Apotex Health Corp. announces closing of upsized bought deal secondary offering

    Toronto, Ontario, September 18, 2026 – Apotex Health Corp. ("Apotex" or the "Company") announced today the closing of the previously announced upsized secondary offering (the "Offering") of common shares of the Company (the "Common Shares") by an affiliate of SK Capital Partners ("SK Capital"), API Investment LP ("Sherfam") and Allan Oberman ("Oberman", and together with SK Capital and Sherfam, the "Selling Shareholders").

  • Sep 15, 2026

    Apotex Health Corp. announces upsize of bought deal secondary offering to $850 million

    Toronto, Ontario, September 15, 2026 - Apotex Health Corp. ("Apotex" or the "Company") announced today that, as a result of strong demand, Apotex, an affiliate of SK Capital Partners ("SK Capital"), API Investment LP ("Sherfam") and Allan Oberman ("Oberman", and together with SK Capital and Sherfam, the "Selling Shareholders") have entered into an amended agreement with the syndicate of underwriters (the "Underwriters") led by RBC Capital Markets, TD Securities Inc., and Scotiabank, as joint lead bookrunners, and BMO Capital Markets and Jefferies Securities, Inc., as joint bookrunners, to increase the size of the previously announced bought deal secondary offering of common shares of the Company (the "Common Shares"). Under the amended agreement, the Underwriters have agreed to purchase 25,000,000 Common Shares from the Selling Shareholders at a purchase price of $34.00 per Common Share for total gross proceeds of approximately $850,000,000 (the "Upsized Offering").

  • Sep 15, 2026

    Apotex Health Corp. announces $750 million bought deal secondary offering

    Toronto, Ontario, September 14, 2026 - Apotex Health Corp. ("Apotex" or the "Company") announced today that Apotex, an affiliate of SK Capital Partners ("SK Capital"), API Investment LP ("Sherfam") and Allan Oberman ("Oberman", and together with SK Capital and Sherfam, the "Selling Shareholders") have entered into an agreement with a syndicate of underwriters (the "Underwriters") led by RBC Capital Markets, TD Securities Inc., and Scotiabank, as joint lead bookrunners, and BMO Capital Markets and Jefferies Securities, Inc., as joint bookrunners, to complete a secondary offering on a bought deal basis (the "Offering") of common shares of the Company (the "Common Shares"). Under the agreement, the Underwriters have agreed to purchase 22,058,825 Common Shares from the Selling Shareholders at a purchase price of $34.00 per Common Share for total gross proceeds of approximately $750,000,050.